Sign up
Log in
Asian Market Insights C-MER Medical Holdings And 2 Other Promising Penny Stocks
Share
Listen to the news

As trade tensions between the U.S. and China show signs of easing, Asian markets have experienced a positive shift in sentiment, with key indices reflecting modest gains. In this context, penny stocks—despite their somewhat outdated label—remain a relevant area for investors seeking potential value in smaller or newer companies. These stocks can offer affordability and growth potential when underpinned by strong financial foundations, making them an intriguing option for those looking to uncover hidden opportunities within the market.

Top 10 Penny Stocks In Asia

Name Share Price Market Cap Rewards & Risks
Advice IT Infinite (SET:ADVICE) THB4.86 THB3.01B ✅ 4 ⚠️ 3 View Analysis >
Chumporn Palm Oil Industry (SET:CPI) THB2.56 THB1.62B ✅ 2 ⚠️ 2 View Analysis >
CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ✅ 4 ⚠️ 3 View Analysis >
YKGI (Catalist:YK9) SGD0.098 SGD41.65M ✅ 2 ⚠️ 3 View Analysis >
Beng Kuang Marine (SGX:BEZ) SGD0.191 SGD38.05M ✅ 4 ⚠️ 3 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.22 SGD8.74B ✅ 5 ⚠️ 0 View Analysis >
Bosideng International Holdings (SEHK:3998) HK$4.02 HK$46.02B ✅ 4 ⚠️ 1 View Analysis >
Lever Style (SEHK:1346) HK$1.08 HK$681.43M ✅ 4 ⚠️ 2 View Analysis >
Goodbaby International Holdings (SEHK:1086) HK$1.11 HK$1.85B ✅ 4 ⚠️ 2 View Analysis >
TK Group (Holdings) (SEHK:2283) HK$1.93 HK$1.61B ✅ 4 ⚠️ 1 View Analysis >

Click here to see the full list of 1,165 stocks from our Asian Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

C-MER Medical Holdings (SEHK:3309)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: C-MER Medical Holdings Limited operates as an investment holding company offering ophthalmic services under the C-MER Dennis Lam brand in Hong Kong and Mainland China, with a market cap of HK$2.04 billion.

Operations: C-MER Medical Holdings Limited generates revenue from its Hong Kong medical business (HK$901.59 million), Mainland China dental services (HK$464.58 million), and ophthalmic operations in Mainland China (HK$546.99 million).

Market Cap: HK$2.04B

C-MER Medical Holdings Limited, with a market cap of HK$2.04 billion, faces challenges typical of penny stocks, such as recent unprofitability and increasing losses over the past five years. Despite this, its operating cash flow significantly covers debt obligations, indicating financial resilience. The company's revenue streams from Hong Kong and Mainland China medical services total HK$1.91 billion for 2024 but have slightly decreased compared to the previous year due to competitive pressures and weakened consumer sentiment. Recent impairments have led to a net loss of HK$135.16 million for 2024 despite proposing a modest dividend payout for shareholders in mid-2025.

SEHK:3309 Debt to Equity History and Analysis as at Apr 2025
SEHK:3309 Debt to Equity History and Analysis as at Apr 2025

China Best Group Holding (SEHK:370)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: China Best Group Holding Limited is an investment holding company that trades in electronic appliances across the People’s Republic of China, Singapore, and Hong Kong, with a market capitalization of HK$2.07 billion.

Operations: The company's revenue is derived from several segments: Building Construction Contracting (HK$72.40 million), Centralised Heating (HK$50.07 million), Geothermal Energy (HK$16.87 million), Customised Technical Support (HK$14.87 million), Property Investment (HK$6.32 million), and Money Lending (HK$6.98 million).

Market Cap: HK$2.07B

China Best Group Holding, with a market cap of HK$2.07 billion, is navigating the complexities of penny stocks through strategic diversification and partnerships. The company has recently entered into agreements to develop a wellness park in Jiangsu Province and a joint venture for humanoid robotics in Hong Kong, highlighting its shift towards digital-oriented services amid real estate challenges in China. Despite being unprofitable with increasing losses over five years, it maintains a satisfactory net debt to equity ratio of 32.8% and sufficient cash runway for over three years due to positive free cash flow growth.

SEHK:370 Debt to Equity History and Analysis as at Apr 2025
SEHK:370 Debt to Equity History and Analysis as at Apr 2025

China Dongxiang (Group) (SEHK:3818)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: China Dongxiang (Group) Co., Ltd. operates in the design, development, marketing, and sale of sport-related apparel, footwear, and accessories both in China and internationally with a market cap of approximately HK$2.23 billion.

Operations: The company generates revenue from its China-Apparel segment, which amounted to CN¥1.72 billion.

Market Cap: HK$2.23B

China Dongxiang (Group) Co., Ltd., with a market cap of HK$2.23 billion, faces challenges typical of penny stocks, including unprofitability and increasing losses over five years at a rate of 42% annually. Despite these hurdles, the company benefits from strong liquidity; its short-term assets (CN¥4.9 billion) comfortably cover both short-term and long-term liabilities. The absence of debt further alleviates financial pressure, though its dividend yield of 7.42% is not supported by earnings or free cash flow. Management and board stability provide some operational continuity amid efforts to improve profitability in the competitive sports apparel sector.

SEHK:3818 Debt to Equity History and Analysis as at Apr 2025
SEHK:3818 Debt to Equity History and Analysis as at Apr 2025

Where To Now?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.